P2RY12 and atrial fibrillation: Using dual therapy with an oral anticoagulant plus a P2Y12 inhibitor for AF patients presenting with ACS or undergoing PCI was based on the hypothesis that oral anticoagulants could replace aspirin to reduce the incidence of ischemic events.